Sign inGet started

VOGELBAUM MARTIN

Insider CIK 1237624 · ITEK Director · NRX Director · CARA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CARA Cara Therapeutics, Inc. A Award deriv2024-06-042024-06-06390,000— $0390,000SEC↗
CARA Cara Therapeutics, Inc. A Award2024-06-042024-06-06301,295— $0411,007SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2023-06-012023-06-0589,923— $089,923SEC↗
CARA Cara Therapeutics, Inc. A Award2023-06-012023-06-0564,724— $0109,712SEC↗
CARA Cara Therapeutics, Inc. S Sale2022-09-142022-09-1610,800$10.28 $111.0K44,988SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2022-06-022022-06-0633,993— $033,993SEC↗
CARA Cara Therapeutics, Inc. A Award2022-06-022022-06-0623,752— $043,912SEC↗
CARA Cara Therapeutics, Inc. A Award2022-06-022022-06-0611,876— $055,788SEC↗
CARA Cara Therapeutics, Inc. S Sale2021-06-072021-06-078,640$13.05 $112.8K20,160SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2021-06-032021-06-0721,600— $021,600SEC↗
CARA Cara Therapeutics, Inc. A Award2021-06-032021-06-0714,400— $028,800SEC↗
CARA Cara Therapeutics, Inc. S Sale2020-11-172020-11-196,000$16.09 $96.5K14,400SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2020-06-042020-06-0821,600— $021,600SEC↗
CARA Cara Therapeutics, Inc. A Award2020-06-042020-06-0814,400— $020,400SEC↗
CARA Cara Therapeutics, Inc. A Award2019-06-042019-07-016,000— $06,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2019-06-042019-06-069,000— $09,000SEC↗
CARA Cara Therapeutics, Inc. A Award2019-06-042019-06-066,000— $06,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2018-06-062018-06-0818,000— $018,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2017-06-212017-06-2315,000— $015,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2016-06-152016-06-1715,000— $015,000SEC↗
CARA Cara Therapeutics, Inc. P Buy2016-03-172016-03-18247,727$4.93 $1.22M3,068,057SEC↗
CARA Cara Therapeutics, Inc. P Buy2016-03-162016-03-18152,273$4.78 $727.9K2,820,330SEC↗
ITEK INOTEK PHARMACEUTICALS COR A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2015-06-082015-06-1013,500— $013,500SEC↗
NRX NephroGenex, Inc. A Award deriv2014-05-152014-05-163,076— $03,076SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-191,215,268— $00SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-19106,697— $00SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-19106,697— $0106,697SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-191,215,268— $01,215,268SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-19106,697— $00SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-191,215,268— $00SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-19494,447— $00SEC↗
NRX NephroGenex, Inc. C Conversion deriv2014-02-142014-02-195,631,531— $00SEC↗
NRX NephroGenex, Inc. A Award2014-02-142014-02-19180,997— $01,326,826SEC↗
NRX NephroGenex, Inc. C Conversion2014-02-142014-02-19203,374— $01,145,829SEC↗
NRX NephroGenex, Inc. C Conversion2014-02-142014-02-19942,455— $0942,455SEC↗
CARA Cara Therapeutics, Inc. C Conversion deriv2014-02-052014-02-056,105,598— $00SEC↗
CARA Cara Therapeutics, Inc. P Buy2014-02-052014-02-05225,818$11.00 $2.48M2,668,057SEC↗
CARA Cara Therapeutics, Inc. C Conversion2014-02-052014-02-052,442,239— $02,442,239SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2014-01-302014-01-3120,000— $020,000SEC↗